beta
Text
1. The Defendant: (a) KRW 10,000,000 for each of the Plaintiff A, and KRW 2,000,000 for Plaintiff D and E, respectively, and KRW 1,048,116,623 for Plaintiff B and C.
Reasons
1. Basic facts
A. Plaintiff A is a child between Plaintiff B and C, and Plaintiff D is a arsen of Plaintiff A, and Plaintiff E is a son of Plaintiff A.
The defendant is a juristic person operating G Hospital (hereinafter referred to as the "Defendant Hospital").
B. 1) Plaintiff A was a congenital heart disease, which is the H’s remainder, and was the congenital heart disease at the Seoul National University Hospital on November 28, 2016, and was the chromatic congenital heart disease, which took the characteristics of Defendant A’s hospital as a serious core loss of the heart to the degree of having the same pressure as the heart and the heart. Plaintiff A performed a diagnosis on June 14:52, 2018. Plaintiff A performed an operation by a diagnosis on the basis of the diagnosis on the following: (a) around 17:3 of the chromatic chromatic chroscopic chroscopic chroscopic chroscopical chroscopic chroscopic chroscopic chroscopic chroscopical chroscopic marization; (b) Plaintiff A took place in the first hospital for treatment and around 19:3 of the rhescopic ropic ch.
After June 11, 2018, Plaintiff A did not take place until June 11, 2018, and the medical professionals of Defendant Hospital provided treatment to regulate symptoms such as heat.
3) 원고 A은 2018. 6. 12. 08:30경 쉰 목소리와 컹컹거리는 기침 증상이 있었고, 피고 병원 의료진이 위 증상을 급성 폐쇄성 후두염으로 판단하고 원고 A에게 에피네프린 1mg/ml 5앰플을 1회 분무하라고 처방을 하였다. 그러나 지시를 실행하던 의료진은 위 처방과 달리 2018. 6. 12. 09:45경 원고 A에게 에피네프린 5앰플(5ml)을 정맥주사하였다. 4) 원고 A은 위 정맥주사 직후인 2018. 6. 12. 09:50경 청색증 및 서맥(느린 맥박수), 혼수의 응급 상황이 발생하였고, 피고 병원 의료진이 경련가능성이 있는 것으로 판단하여 원고 A에게 진정제인 로라제팜을 투여하였으며, 최초 신생아용 기도삽관(크기 3.0)을 사용하여 기관삽관에 실패하였고, 이후 4.5의...